Responses
Liver
Original research
Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)
Compose a Response to This Article
Other responses
No responses have been published for this article.